Summary:
The purpose of this study is to evaluate the effectiveness and safety of the investigational drug, DA-8159, in subjects with erectile dysfunction
Qualified Participants Must:
• be in a monogomous sexual relationship for at least 6 months
•
be at least 19 years old
•
have a history of ED (defined as the inability to attain and maintain an erection of the penis sufficient to permit satisfactory sexual intercourse) for at least 3 months
Qualified Participants May Receive:
up to $250.00 for completion of the study